MPR Weekly Dose

MPR Weekly Dose

Each week the MPR team brings you the top stories from the world of medicine and pharma in a matter of minutes. With 35 years of publishing drug information behind us, you can rely on MPR to provide accurate and up-to-date news.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(286)

MPR Weekly Dose 95 - Interview with Dr Preeti Malani, Chief Health Officer and Professor of Medicine in the Division of Infectious Diseases at the University of Michigan

MPR Weekly Dose 95 - Interview with Dr Preeti Malani, Chief Health Officer and Professor of Medicine in the Division of Infectious Diseases at the University of Michigan

Dr Preeti Malani, Chief Health Officer at UM, joined us to talk about the current state of the COVID-19 pandemic, including vaccine hesitancy, mandates, boosters and how the future may unfold.

7 Okt 202123min

MPR Weekly Dose 94 - COVID Vaccine Booster Doses; Pediatric Vaccine Trial; Parental Vaccine Hesitancy; Remdesivir and Hospitalization Risk; Atopic Dermatitis Treatment

MPR Weekly Dose 94 - COVID Vaccine Booster Doses; Pediatric Vaccine Trial; Parental Vaccine Hesitancy; Remdesivir and Hospitalization Risk; Atopic Dermatitis Treatment

The Pfizer-BioNTech vaccine gets Emergency Use Authorization for booster dose in certain individuals; A smaller dose appears safe and effective in children; Janssen share booster data for their vaccin...

24 Sep 202113min

MPR Weekly Dose 93 - Mandatory Opioid Prescriber Education; Rise in Delta-8 THC Products; Brukinsa and Exkivity Approved; Warning Letters for Supplement Companies

MPR Weekly Dose 93 - Mandatory Opioid Prescriber Education; Rise in Delta-8 THC Products; Brukinsa and Exkivity Approved; Warning Letters for Supplement Companies

This week the FDA weigh up mandatory education for opioid prescribers; There's an increase in the sale of strong psychoactive THC products; Brukinsa and Exkivity gain approvals for lymphoma and NSCLC,...

17 Sep 202113min

MPR Weekly Dose 92 - AAP Vaccination Guidance; Moderna Booster; JAK Inhibitor Warnings; New Migraine Treatment Nasal Spray; Hold Placed on Phenylketonuria

MPR Weekly Dose 92 - AAP Vaccination Guidance; Moderna Booster; JAK Inhibitor Warnings; New Migraine Treatment Nasal Spray; Hold Placed on Phenylketonuria

This week we have news on pediatric influenza vaccine guidance; Moderna submit data for their COVID-19 booster dose; There's new FDA warnings for some JAK inhibitors; Trudhesa nasal spray is approved;...

10 Sep 202111min

MPR Weekly Dose 91 - First Full COVID-19 Vaccine Approval; Pfizer Submit for Third Dose; AAP Advises on Off-Label Vaccinations; COVID Antibody Tx; Moderna BLA Submission

MPR Weekly Dose 91 - First Full COVID-19 Vaccine Approval; Pfizer Submit for Third Dose; AAP Advises on Off-Label Vaccinations; COVID Antibody Tx; Moderna BLA Submission

The first COVID-19 vaccine is fully approved by the FDA, we'll go into all that that entails and also news regarding booster doses, off-label recommendations, promising antibody treatments and a BLA s...

26 Aug 202111min

MPR Weekly Dose 90 - COVID-19 Vaccine Booster Dose; Vaccine for Tick-Borne Encephalitis; Jardiance Approval; FDA Wristband Warning; Jemperli Accelerated Approval

MPR Weekly Dose 90 - COVID-19 Vaccine Booster Dose; Vaccine for Tick-Borne Encephalitis; Jardiance Approval; FDA Wristband Warning; Jemperli Accelerated Approval

This week we have significant news on the status of a third COVID-19 vaccine booster dose, as well as news for an encephalitis vaccine, another jardiance indication, an FDA warning concerning patient ...

19 Aug 202111min

MPR Weekly Dose 89 - COVID Vaccine Booster Dose; Vaccines Recommended in Pregnancy; Post-Vaccine Myocarditis Study; Moderna Efficacy at 6 Months; Pompe Disease Tx; FDA Denies Roxadustat

MPR Weekly Dose 89 - COVID Vaccine Booster Dose; Vaccines Recommended in Pregnancy; Post-Vaccine Myocarditis Study; Moderna Efficacy at 6 Months; Pompe Disease Tx; FDA Denies Roxadustat

Big news on the COVID-19 vaccine booster dose. The CDC issues new recommendations on vaccines. What protection the Moderna vaccine offers after 6 months. A treatment approved for Pompe disease. And th...

13 Aug 202111min

MPR Weekly Dose 88 - Postexposure Tx for COVID-19; Novel lupus treatment; Higher dose naloxone; Clozapine REMS changes; Istodax indication withdrawn

MPR Weekly Dose 88 - Postexposure Tx for COVID-19; Novel lupus treatment; Higher dose naloxone; Clozapine REMS changes; Istodax indication withdrawn

The FDA authorizes a postexposure prophylaxis for COVID-19; a new treatment is okay'd for lupus; a higher dose naloxone nasal spray became available; the risk evaluation and mitigation program for Clo...

6 Aug 202110min

Populært innen Helse

fastlegen
rss-gukild-johaug
psykodrama
hvordan-har-du-det-mann
lydartikler-fra-aftenposten
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-skravla-gar
foreldreradet
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
morten-ramm-lar-kakla-ga-til-du-sovner
hjernesterk
hormonelle-frida
klimaks
rss-lopedrommen
g-punktet
rss-kunsten-a-leve
apent-forhold
rss-loping-for-nybegynnere
hverdagspsyken